Best 52 Week Nasdaq Low Stocks to Buy in July 19, 2025
| Number | Ticker | Exchange | Market Cap | Price | 52 Weeks Low | 52 Weeks High | Analyst Decision |
|---|---|---|---|---|---|---|---|
| 1 | Nasdaq | $371.6B | $155.07 | $151.90 | $180.43 | Buy | |
| 2 | Nasdaq | $78.4B | $276.98 | $276.41 | $567.26 | Strong Buy | |
| 3 | Nasdaq | $73.0B | $86.84 | $85.32 | $109.30 | Buy | |
| 4 | Nasdaq | $30.7B | $355.21 | $352.37 | $584.01 | Buy | |
| 5 | Nasdaq | $28.1B | $27.95 | $27.89 | $80.59 | Buy | |
| 6 | Nasdaq | $19.5B | $71.42 | $69.98 | $86.24 | Buy | |
| 7 | Nasdaq | $12.5B | $182.96 | $182.11 | $365.23 | Buy | |
| 8 | Nasdaq | $9.9B | $62.61 | $61.34 | $91.25 | Buy | |
| 9 | Nasdaq | $7.7B | $49.01 | $47.90 | $83.98 | Buy | |
| 10 | Nasdaq | $5.7B | $70.18 | $69.12 | $122.83 | Strong Buy | |
| 11 | MMSIMerit Medical Systems Inc. | Nasdaq | $5.5B | $83.02 | $82.62 | $111.45 | Buy |
| 12 | Nasdaq | $4.7B | $84.35 | $82.39 | $238.32 | Buy | |
| 13 | Nasdaq | $4.1B | $17.22 | $17.05 | $22.26 | Buy | |
| 14 | BCCBoise Cascade L.L.C. | Nasdaq | $3.2B | $83.94 | $83.54 | $155.42 | Buy |
| 15 | Nasdaq | $2.4B | $47.65 | $47.46 | $70.56 | Buy | |
| 16 | Nasdaq | $2.1B | $35.46 | $35.20 | $63.00 | Strong Buy | |
| 17 | Nasdaq | $1.9B | $14.45 | $14.03 | $40.98 | Buy | |
| 18 | Nasdaq | $1.7B | $22.73 | $22.60 | $63.20 | Strong Buy | |
| 19 | Nasdaq | $1.6B | $26.78 | $26.48 | $33.85 | Buy | |
| 20 | Nasdaq | $1.3B | $23.19 | $23.08 | $49.93 | Buy | |
| 21 | Nasdaq | $1.1B | $10.50 | $10.26 | $25.50 | Strong Buy | |
| 22 | Nasdaq | $933.1M | $10.45 | $10.45 | $14.12 | Strong Buy | |
| 23 | Nasdaq | $885.9M | $13.41 | $13.12 | $34.94 | Buy | |
| 24 | Nasdaq | $302.5M | $9.46 | $9.42 | $22.38 | Buy | |
| 25 | Nasdaq | $220.4M | $14.20 | $14.07 | $19.42 | Strong Buy |
Share on Social Networks:
Disclaimer
The FinQuota filters have identified what they believe to be the "Best 52 Week Low Nasdaq Stocks to Buy Today" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.